Meta Pixel

News and Announcements

AXIchain partnering for success with DLL

  • Published January 11, 2022 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

AXIchain is pleased to announce it is partnering with De Lage Landen (DLL) to combine the
technology solutions of AXIchain and the financial power of DLL to provide livestock finance to
AXIchain customers.

“DLL has a long history of partnering with market leaders in their field. We are also proud to now be partnering with AXIchain Pty Ltd, a new and innovative player with a livestock funding solution for the Australian agriculture market,” said Greg Crawford, National Sales Manager Food & Agricultural Business at DLL.

Register Interest

Continuing the mission of delivering smart digital solutions to the red meat and livestock industry, AXIchain has harnessed the opportunity to provide a competitive edge to its customers. Seamless integration of De Lage Landen’s financial services with AXIchain technology will provide customers with an all-in-one solution for livestock.

“AXIchain is excited to partner with DLL to deliver technology-driven livestock finance to Australia’s agriculture industry. This innovation is underpinned by AXIchain lifetime provenance, traceability and trade technology providing digital visibility of livestock and its performance through the term of the loan,” said Linda Woodford, Founder and CEO of AXIchain.

With the cost of purchasing replacement and feeder cattle at record levels, coupled with higher than average rainfall and pasture production, this innovation into the market will provide greater choice on finance options to help producers maintain optimum production levels.

As sophisticated technologies on-farm are changing the way food and fibre is produced, the same
progress to find enhancements in business management is needed. AXIchain is proud to lead the
industry with this initiative.

Register Interest

Capital Insights
The RBA Just Validated the Shift to Private Credit

With the RBA’s latest decision confirming the ‘higher for longer’ environment, sophisticated investors are rotating capital from rate-sensitive public markets into private credit for superior, lower-volatility yields. The era of cheap money is over, making private credit a necessary multi-year positioning decision.

Capital Insights
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t

The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.

Join over 45,000+ sophisticated investors

Join Now